Abnormalities in systemic norepinephrine kinetics in human congestive heart failure

D. Davis, R. Baily, R. Zelis

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

A high venous plasma norepinephrine (NE) level is a predictor of poor prognosis in congestive heart failure (CHF). To evaluate the mechanisms responsible for the high plasma NE in CHF, NE kinetics were studied in 19 patients with CHF and 18 normal subjects during a 90-min steady-state intravenous infusion of tracer [3H]NE of high specific activity. Venous plasma NE between 70 and 90 min of infusion was significantly higher in the CHF patients (CHF, 634, and normal, 247 pg/ml; P < 0.001). The following equations were used: NE clearance = [3H]NE infusion rate (dpm/min)/plasma [3H]NE (dpm/l), and NE spillover = [3H]NE infusion rate (dpm/min)/[3H]NE specific activity (dpm/nmol). In CHF, a decreased clearance and an increased spillover contributed nearly equally to the high plasma NE (NE clearance: CHF, 0.99; normal, 1.48 l·min-1·m-2; P < 0.001; NE spillover: CHF, 3.60; normal, 2.08 nmol·min-1·m-2; P < 0.001). These data document that both NE clearance and NE spillover are abnormal in CHF, and they raise the new possibility that the factors responsible for the reduced NE clearance could be related to the factors linking a high plasma NE with early mortality.

Original languageEnglish (US)
Pages (from-to)17/6
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume254
Issue number6
StatePublished - Jan 1 1988

Fingerprint

Norepinephrine
Heart Failure
Intravenous Infusions

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Physiology
  • Physiology (medical)

Cite this

@article{90a8cc31eb91495aa3ad107837f4aebc,
title = "Abnormalities in systemic norepinephrine kinetics in human congestive heart failure",
abstract = "A high venous plasma norepinephrine (NE) level is a predictor of poor prognosis in congestive heart failure (CHF). To evaluate the mechanisms responsible for the high plasma NE in CHF, NE kinetics were studied in 19 patients with CHF and 18 normal subjects during a 90-min steady-state intravenous infusion of tracer [3H]NE of high specific activity. Venous plasma NE between 70 and 90 min of infusion was significantly higher in the CHF patients (CHF, 634, and normal, 247 pg/ml; P < 0.001). The following equations were used: NE clearance = [3H]NE infusion rate (dpm/min)/plasma [3H]NE (dpm/l), and NE spillover = [3H]NE infusion rate (dpm/min)/[3H]NE specific activity (dpm/nmol). In CHF, a decreased clearance and an increased spillover contributed nearly equally to the high plasma NE (NE clearance: CHF, 0.99; normal, 1.48 l·min-1·m-2; P < 0.001; NE spillover: CHF, 3.60; normal, 2.08 nmol·min-1·m-2; P < 0.001). These data document that both NE clearance and NE spillover are abnormal in CHF, and they raise the new possibility that the factors responsible for the reduced NE clearance could be related to the factors linking a high plasma NE with early mortality.",
author = "D. Davis and R. Baily and R. Zelis",
year = "1988",
month = "1",
day = "1",
language = "English (US)",
volume = "254",
pages = "17/6",
journal = "American Journal of Physiology",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "6",

}

Abnormalities in systemic norepinephrine kinetics in human congestive heart failure. / Davis, D.; Baily, R.; Zelis, R.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 254, No. 6, 01.01.1988, p. 17/6.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Abnormalities in systemic norepinephrine kinetics in human congestive heart failure

AU - Davis, D.

AU - Baily, R.

AU - Zelis, R.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - A high venous plasma norepinephrine (NE) level is a predictor of poor prognosis in congestive heart failure (CHF). To evaluate the mechanisms responsible for the high plasma NE in CHF, NE kinetics were studied in 19 patients with CHF and 18 normal subjects during a 90-min steady-state intravenous infusion of tracer [3H]NE of high specific activity. Venous plasma NE between 70 and 90 min of infusion was significantly higher in the CHF patients (CHF, 634, and normal, 247 pg/ml; P < 0.001). The following equations were used: NE clearance = [3H]NE infusion rate (dpm/min)/plasma [3H]NE (dpm/l), and NE spillover = [3H]NE infusion rate (dpm/min)/[3H]NE specific activity (dpm/nmol). In CHF, a decreased clearance and an increased spillover contributed nearly equally to the high plasma NE (NE clearance: CHF, 0.99; normal, 1.48 l·min-1·m-2; P < 0.001; NE spillover: CHF, 3.60; normal, 2.08 nmol·min-1·m-2; P < 0.001). These data document that both NE clearance and NE spillover are abnormal in CHF, and they raise the new possibility that the factors responsible for the reduced NE clearance could be related to the factors linking a high plasma NE with early mortality.

AB - A high venous plasma norepinephrine (NE) level is a predictor of poor prognosis in congestive heart failure (CHF). To evaluate the mechanisms responsible for the high plasma NE in CHF, NE kinetics were studied in 19 patients with CHF and 18 normal subjects during a 90-min steady-state intravenous infusion of tracer [3H]NE of high specific activity. Venous plasma NE between 70 and 90 min of infusion was significantly higher in the CHF patients (CHF, 634, and normal, 247 pg/ml; P < 0.001). The following equations were used: NE clearance = [3H]NE infusion rate (dpm/min)/plasma [3H]NE (dpm/l), and NE spillover = [3H]NE infusion rate (dpm/min)/[3H]NE specific activity (dpm/nmol). In CHF, a decreased clearance and an increased spillover contributed nearly equally to the high plasma NE (NE clearance: CHF, 0.99; normal, 1.48 l·min-1·m-2; P < 0.001; NE spillover: CHF, 3.60; normal, 2.08 nmol·min-1·m-2; P < 0.001). These data document that both NE clearance and NE spillover are abnormal in CHF, and they raise the new possibility that the factors responsible for the reduced NE clearance could be related to the factors linking a high plasma NE with early mortality.

UR - http://www.scopus.com/inward/record.url?scp=0023901714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023901714&partnerID=8YFLogxK

M3 - Article

C2 - 3377075

AN - SCOPUS:0023901714

VL - 254

SP - 17/6

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1849

IS - 6

ER -